Interv Akut Kardiol. 2015;14(1):14-17

Troponins and minimal myocardial damage after pacemaker implantation - pilot study

Tomáš Hnátek1,2, Miloš Táborský2, Martin Malý1, Libor Kameník1, Simona Littnerová3, Pavel Sedloň1, Jana Luxová1, Marta Fišerová1, Šárka Hamouzová1, Miroslav Zavoral1
1 Kardiologické odd., Interní klinika 1. LF UK a ÚVN, Praha
2 I. interní kardiologická klinika, LF UP a FN Olomouc
3 Institut biostatistiky a analýz, Masarykova univerzita, Brno

Introduction: Cardiac troponins are highly specific markers of myocardial damage. The aim of our investigation was to determine the

correlation between pacemaker implantation and elevation of cardiospecific markers.

Aim: To compare the elevation of troponin I in group of patients with the implantation of pacemaker (single or dual chamber) with active

lead and unselected population of cardiologic patients.

Method: A defined group of 230 patients were indicated for the pacemaker implantation. The values of cardiospecific markers

(troponin I, CKMB and myoglobin) were measured before the implantation and repeated 6 and 18 hours later. Monitored factors were

fluoroscopic time, the number of attempts of pacemaker implantation (attachment to myocardium), single chamber versus dual chamber

pacemaker implantation and other clinical data.

Results: The mean age was 77.9 ± 8.0 years (median 79.5). Females formed 44 % of the group. A total of 136 double chamber and 94 single

chamber pacemakers were implanted. The average time of fluoroscopy was 38.8 ± 22.0 seconds (median 33.5 s). In the whole group of

patients troponin I increased from the initial 0.02 ± 0.07 ug/l to 0.18 ± 0.17, p < 0.001 (Wilcoxon test) 6 hours later and decrease to 0.09

± 0.18 ug/l 18 hours later, p < 0.001 (Wilcoxon test). There were minor changes in other cardiospecific markers. The correlation between

serum levels of troponin I after the implantation of pacemaker and fluoroscopic time in the whole group of 230 patients was set, (Spearman

correlation coeficient =-0.39, p < 0.001 resp. 0.37, p < 0.001) after 6 and 18 hours respectively.

Conclusion: A mild troponin I elevation after the uncomplicated pacemaker implantation with active lead electrode system is a common

phenomenon. We didnt find correlation betwen troponin I elevation and difficulty of the procedure.

Keywords: pacing, troponin, primoimplantation, myocardial damage

Published: April 20, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hnátek T, Táborský M, Malý M, Kameník L, Littnerová S, Sedloň P, et al.. Troponins and minimal myocardial damage after pacemaker implantation - pilot study. Interv Akut Kardiol. 2015;14(1):14-17.
Download citation

References

  1. Widimsky P, Kala P, Rokyta R. Summary of the 2012 ESC Guidelines for the management of acute myocardial infarction in patiens presenting with ST-segment elevations. Prepared by Czech Society of Cardiology. Cor et Vasa, Volume 54, Issue 5, September-October 2012: e273-e289. Go to original source...
  2. Ferlitsch A, Matejcek E, Steinbereithner K, Czerny EM, Wiche S. The diagnostic value of CK-isoenzymes in suspected acute myocardial infarction. Deutsche Medizinische Wochenschrift, 1976; 101(9): 312-317. Go to original source... Go to PubMed...
  3. Špaček R. Infarkt myokardu - diagnostika, Postgraduální medicína 2002; 8: 881-890.
  4. Hartshorne DJ. Interactions of Desensitized Actomyosin with Tropomyosin, Troponin A, Troponin B, and Polyanions, The Journal of General Physiology, 1970; 55. Go to original source... Go to PubMed...
  5. Martignani D, Biffi M, Ziacchi M, Saporito D, Valzania C, Bertini M, Domenichini G, Branzi A, Boriani G. Troponin I Rise After Pacemaker Implantation at the Time of "Universal Definition of Myocardial Infarction". American Journal of Cardiology, Volume 103, Issue 8, April 2009: 1061-1065. Go to original source... Go to PubMed...
  6. Boss ChJ, Gough S, Wheather M, Mebak S, More R. Effects of Transvenous Pacing on Cardiac Troponin Release. Pacing & Clinical Electrophysiology. Vol. 27 (9), September 2004: 1264-1268. Go to original source... Go to PubMed...
  7. Altin T, Akyurek O, Vurgun K, Beton O, Sayin T, Kilickap M, Karaoguz R, Guldal M, Erol C. Effect of Transvenous Cardiac Resynchronization Therapy Device Implantation on Cardiac Troponin I Release. Pacing & Clinical Electrophysiology. 30 (11), November 2007: 1356-1362. Go to original source... Go to PubMed...
  8. Sbarouni E, Georgiadou P, Panagiotakos D, Livanis E, Theodorakis GN, Kremastinos DT. The ischemia-modified albumin in relation to pacemaker and defibrillator implantation. Pacing And Clinical Electrophysiology: PACE [Pacing Clin Electrophysiol], 2008; 31(1): 83-87. Go to original source... Go to PubMed...
  9. Brandt RR, Filzmaier K, Hanrath P. Circulating cardiac troponin I in acute pericarditis. The American Journal of Cardiology, Vol. 87(11): 1326-1328. Go to original source... Go to PubMed...
  10. Horwitch TA, Jingnesh P, Mac-Lellan WR, Fonarrow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive. Circulation. 2003; 108(7): 833-838. Go to original source... Go to PubMed...
  11. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J, Vol. 130 (6), December 1995: 1276-1282. Go to original source... Go to PubMed...
  12. Giannitsis, Evangelos MD, Muller-Bardorff, Margit MD, Kurowski, Volkhard MD, Weidtmann, Britta MD, Wiegand, Uwe MD, Kampmann, Markus MD, Katus, Hugo A. MD. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism.Circulation. 2000; 102(2): 211-217. Go to original source... Go to PubMed...
  13. Meyer T, Binder L, Hruska N, et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol., 2000; 36: 1632-1636. Go to original source... Go to PubMed...
  14. Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation. 2003; 108: 2191-2194. Go to original source... Go to PubMed...
  15. Diris JHC, Hackeng ChM, Kooman JP, Pinto YM MD, PhD, Hermens WT, van Dieijen-Visser MP. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation. 2004; 109: 23-25. Go to original source... Go to PubMed...
  16. Diris JHC, Hackeng CHM, Kooman JP, Yigal MP, Hermes WT, van Dieijen-Visser MP. Impaired renal clearence explains elevated troponin T fragments in hemodialysis patiens. Circulation, 2004; 109: 23-25. Go to original source... Go to PubMed...
  17. Ebelt H, Werdan K. Septischer Kreislaufschock und septische Kardiomyopathie, Med.Klin.Intensivmed. Notfmed. 2012; 107: 24-28. Go to original source... Go to PubMed...
  18. Fromm RE. Cardiac troponins in the intensive care unit: Commons cause of increased levels and interpretation. Crit Care Med. 2007; 35(2): 584-588. Go to original source... Go to PubMed...
  19. Newby KI, Jesse RL, et al. ACCF 2012 Expert Konsensus Dokument on Practical Clinical Considerations in the Interpretation of Troponin Elevations, Journal of the American College of Cardiology, 2012; 60(23). Go to original source... Go to PubMed...
  20. Mahajan VS, Jarolim P. How to interpret Elevated Cardiac Troponin Levels, Circulation, 2011; 124: 2350-2354. Go to original source... Go to PubMed...
  21. Davoodi G, Mohammadi V, et al. Detection of myocardial injury due to defibrillation threshold checking after insertion of implantable cardioverter/defibrillators. Acta Cardiologica, 2013; 68(2): 167-172. Go to original source... Go to PubMed...
  22. Geller JCh, Rosen MR. Persistent T-wave changes after alteration of the ventricular activation sequence-New insights into cellular mechanisms of, Cardiac memory'. Circulation. 1993; 88(4): Part 1. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.